Similarly, STAT1 activation may induce antiproliferative and proapoptotic responses and enhance antitumor immunity during carcinogenesis, while STAT3 activation enhances tumor cell survival/proliferation, motility, and immune tolerance (46). Here, STAT1 is linked to neoplasm.